ARTICLE | Company News
Quest, Vasogen commercialization deal
November 7, 2001 8:00 AM UTC
Quest Diagnostics (DGX) received exclusive U.S. distribution rights to an immune modulation therapy developed by Vasogen (TSE:VAS; MEW). The product is in clinical testing for cardiovascular, autoimmu...